Sebastian Wanless
Corporate Officer/Principal bei TCB Newco Ltd.
Profil
Sebastian Wanless is currently working as a Senior Clinical Director at TCB Newco Ltd.
He previously worked as a Senior Medical Director at Bristol-Myers Squibb Foundation from 2003 to 2007.
Additionally, he worked as a Director-Clinical Operations at TC Biopharm (Holdings) Plc from 2020 to 2022.
Aktive Positionen von Sebastian Wanless
Unternehmen | Position | Beginn |
---|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sebastian Wanless
Unternehmen | Position | Ende |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01.09.2022 |
Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01.01.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Bristol-Myers Squibb Foundation | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |